Bromhexine Impurity F, with the CAS number 14860-48-1, is a chemical compound associated with the pharmaceutical agent bromhexine, which is primarily used as a mucolytic agent to aid in the treatment of respiratory conditions. This impurity is characterized by its specific molecular structure, which may differ slightly from the parent compound, bromhexine, affecting its pharmacological properties. Typically, impurities like Bromhexine Impurity F are identified through analytical techniques such as chromatography and mass spectrometry. The presence of impurities in pharmaceutical formulations is critical to monitor, as they can influence the efficacy and safety of the drug. While specific physical and chemical properties such as melting point, solubility, and spectral data may vary, they are essential for quality control in pharmaceutical manufacturing. Regulatory guidelines often dictate acceptable levels of impurities to ensure that the final product meets safety and efficacy standards. Understanding the characteristics of such impurities is vital for pharmaceutical development and compliance with health regulations.

Bromhexine Impurity F

14860-48-1: Bromhexine Impurity F, with the CAS number 14860-48-1, is a chemical compound associated with the pharmaceutical agent bromhexine, which is primarily used as a mucolytic agent to aid in the treatment of respiratory conditions. This impurity is characterized by its specific molecular structure, which may differ slightly from the parent compound, bromhexine, affecting its pharmacological properties. Typically, impurities like Bromhexine Impurity F are identified through analytical techniques such as chromatography and mass spectrometry. The presence of impurities in pharmaceutical formulations is critical to monitor, as they can influence the efficacy and safety of the drug. While specific physical and chemical properties such as melting point, solubility, and spectral data may vary, they are essential for quality control in pharmaceutical manufacturing. Regulatory guidelines often dictate acceptable levels of impurities to ensure that the final product meets safety and efficacy standards. Understanding the characteristics of such impurities is vital for pharmaceutical development and compliance with health regulations.

CAS 14860-48-1

Bromhexine Impurity F

Bromhexine Impurity 5 HCl

Ref: 4Z-B-3720

2,4-Dibromo-6-((cyclohexylamino)methyl)aniline

Ref: ST-EA-CP-B62029